October 31, 2011

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL 2011 RESULTS (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), a biopharmaceutical company developing
drug candidates for the prevention and treatment of cancer, today announced financial results for the year ended July 31, 2011.